Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells

被引：40

作者：

Kuroda, Yukiko ^{[1
]}

Mitsui, Takao ^{[1
]}

Kunishige, Makoto ^{[1
]}

Matsumoto, Toshio ^{[1
]}

机构：

[1] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 7708503, Japan

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2006年 / 348卷 / 03期

关键词：

respiratory chain complex; membrane potential; cytofluorometric analysis; siRNA;

D O I：

10.1016/j.bbrc.2006.06.201

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We investigated the effect of parkin on mitochondrial function and apoptosis in SH-SY5Y, L6, RD, and COS-1 cells. Wild-type parkin attenuated reactive oxygen species (ROS) production in SH-SY5Y cells and mutant parkin enhanced ROS production in SH-SY5Y and L6 cells. Reactive oxygen intermediates, that were detected in mitochondria, were decreased in cells with overexpression of parkin. Parkin prevented apoptosis and enhanced mitochondrial membrane potentials in SH-SY5Y and L6 cells not in COS-I cells. Expressions and enzymatic activities of mitochondrial respiratory chain complexes were not uniformly enhanced but those of complex I were selectively enhanced. The present results suggest the cell-selective function of parkin, i.e., parkin possesses anti-apoptotic and anti-oxidant function in neuronal or myogenic cells but not in kidney cells. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：787 / 793

页数：7

共 39 条

[1]

Alam ZI, 1997, J NEUROCHEM, V69, P1326

[2] Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra [J].

Alam, ZI ;

Jenner, A ;

Daniel, SE ;

Lees, AJ ;

Cairns, N ;

Marsden, CD ;

Jenner, P ;

Halliwell, B .

JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) :1196-1203

[3]

Beal MF, 2003, ANN NY ACAD SCI, V991, P120

[4] Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].

Betarbet, R ;

Sherer, TB ;

MacKenzie, G ;

Garcia-Osuna, M ;

Panov, AV ;

Greenamyre, JT .

NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306

[5] Glutathione, iron and Parkinson's disease [J].

Bharath, S ;

Hsu, M ;

Kaur, D ;

Rajagopalan, S ;

Andersen, JK .

BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) :1037-1048

[6] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].

Conway, KA ;

Harper, JD ;

Lansbury, PT .

NATURE MEDICINE, 1998, 4 (11) :1318-1320

[7]

Czlonkowska A., 2002, Med Sci Monit, V8, P165

[8] Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death [J].

Darios, F ;

Corti, O ;

Lücking, CB ;

Hampe, C ;

Muriel, MP ;

Abbas, N ;

Gu, WJ ;

Hirsch, EC ;

Rooney, T ;

Ruberg, M ;

Brice, A .

HUMAN MOLECULAR GENETICS, 2003, 12 (05) :517-526

[9] Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-xL in osteosarcoma cells [J].

Dey, R ;

Moraes, CT .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) :7087-7094

[10] Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons [J].

Goldberg, MS ;

Fleming, SM ;

Palacino, JJ ;

Cepeda, C ;

Lam, HA ;

Bhatnagar, A ;

Meloni, EG ;

Wu, NP ;

Ackerson, LC ;

Klapstein, GJ ;

Gajendiran, M ;

Roth, BL ;

Chesselet, MF ;

Maidment, NT ;

Levine, MS ;

Shen, J .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43628-43635

← 1 2 3 4 →